The combination of a bacterial polysaccharide and tamoxifen inhibits angiogenesis and tumour growth.
Tanaka
N G
NG
Research Institute, Daiichi Pharmaceutical Co., Ltd., Tokyo, Japan.
Sakamoto
N
N
Korenaga
H
H
Inoue
K
K
Ogawa
H
H
Osada
Y
Y
D000818:Animals; D001173:Arthrobacter; D001943:Breast Neoplasms / Q000098:blood supply* / Q000188:drug therapy; D004357:Drug Synergism; D004730:Endothelium, Vascular / Q000166:cytology / Q000187:drug effects; D005260:Female; D006801:Humans; D066298:In Vitro Techniques; D051379:Mice; D008807:Mice, Inbred BALB C; D008819:Mice, Nude; D009389:Neovascularization, Pathologic; D011135:Polysaccharides, Bacterial / Q000627:therapeutic use*; D013629:Tamoxifen / Q000627:therapeutic use*; D014183:Transplantation, Heterologous
D011135:Polysaccharides, Bacterial; D013629:Tamoxifen